162 related articles for article (PubMed ID: 15358300)
1. Isoform-specific phosphoinositide 3-kinase inhibitors from an arylmorpholine scaffold.
Knight ZA; Chiang GG; Alaimo PJ; Kenski DM; Ho CB; Coan K; Abraham RT; Shokat KM
Bioorg Med Chem; 2004 Sep; 12(17):4749-59. PubMed ID: 15358300
[TBL] [Abstract][Full Text] [Related]
2. Cloning of a human phosphoinositide 3-kinase with a C2 domain that displays reduced sensitivity to the inhibitor wortmannin.
Domin J; Pages F; Volinia S; Rittenhouse SE; Zvelebil MJ; Stein RC; Waterfield MD
Biochem J; 1997 Aug; 326 ( Pt 1)(Pt 1):139-47. PubMed ID: 9337861
[TBL] [Abstract][Full Text] [Related]
3. PI3-kinase upregulation and involvement in spontaneous tone in arteries from DOCA-salt rats: is p110delta the culprit?
Northcott CA; Hayflick JS; Watts SW
Hypertension; 2004 Apr; 43(4):885-90. PubMed ID: 14993194
[TBL] [Abstract][Full Text] [Related]
4. [PI3-kinase inhibitors LY294002 and wortmannin have different effects on proliferation of murine embryonic stem cells].
Lianguzova MS; Chuĭkin IA; Nordheim A; Pospelov VA
Tsitologiia; 2006; 48(7):560-8. PubMed ID: 17087147
[TBL] [Abstract][Full Text] [Related]
5. Direct inhibition of the signaling functions of the mammalian target of rapamycin by the phosphoinositide 3-kinase inhibitors, wortmannin and LY294002.
Brunn GJ; Williams J; Sabers C; Wiederrecht G; Lawrence JC; Abraham RT
EMBO J; 1996 Oct; 15(19):5256-67. PubMed ID: 8895571
[TBL] [Abstract][Full Text] [Related]
6. A versatile high-throughput screen for inhibitors of lipid kinase activity: development of an immobilized phospholipid plate assay for phosphoinositide 3-kinase gamma.
Fuchikami K; Togame H; Sagara A; Satoh T; Gantner F; Bacon KB; Reinemer P
J Biomol Screen; 2002 Oct; 7(5):441-50. PubMed ID: 14599360
[TBL] [Abstract][Full Text] [Related]
7. Urokinase-induced smooth muscle cell migration requires PI3-K and Akt activation.
Galaria II; Nicholl SM; Roztocil E; Davies MG
J Surg Res; 2005 Jul; 127(1):46-52. PubMed ID: 15964303
[TBL] [Abstract][Full Text] [Related]
8. Biochemical and pharmacological studies with KT7692 and LY294002 on the role of phosphatidylinositol 3-kinase in Fc epsilon RI-mediated signal transduction.
Yano H; Agatsuma T; Nakanishi S; Saitoh Y; Fukui Y; Nonomura Y; Matsuda Y
Biochem J; 1995 Nov; 312 ( Pt 1)(Pt 1):145-50. PubMed ID: 7492304
[TBL] [Abstract][Full Text] [Related]
9. The phosphatidylinositol 3-kinase inhibitor LY294002 potently blocks K(V) currents via a direct mechanism.
El-Kholy W; Macdonald PE; Lin JH; Wang J; Fox JM; Light PE; Wang Q; Tsushima RG; Wheeler MB
FASEB J; 2003 Apr; 17(6):720-2. PubMed ID: 12586735
[TBL] [Abstract][Full Text] [Related]
10. Small molecule inhibitors of the PI3-kinase family.
Knight ZA
Curr Top Microbiol Immunol; 2010; 347():263-78. PubMed ID: 20473788
[TBL] [Abstract][Full Text] [Related]
11. Radiosensitization of human tumor cells by the phosphatidylinositol3-kinase inhibitors wortmannin and LY294002 correlates with inhibition of DNA-dependent protein kinase and prolonged G2-M delay.
Rosenzweig KE; Youmell MB; Palayoor ST; Price BD
Clin Cancer Res; 1997 Jul; 3(7):1149-56. PubMed ID: 9815794
[TBL] [Abstract][Full Text] [Related]
12. Class I phosphoinositide 3-kinase p110beta is required for apoptotic cell and Fcgamma receptor-mediated phagocytosis by macrophages.
Leverrier Y; Okkenhaug K; Sawyer C; Bilancio A; Vanhaesebroeck B; Ridley AJ
J Biol Chem; 2003 Oct; 278(40):38437-42. PubMed ID: 12869549
[TBL] [Abstract][Full Text] [Related]
13. Evidence for a functional association between phosphatidylinositol 3-kinase and c-src in the spreading response of osteoclasts to colony-stimulating factor-1.
Grey A; Chen Y; Paliwal I; Carlberg K; Insogna K
Endocrinology; 2000 Jun; 141(6):2129-38. PubMed ID: 10830300
[TBL] [Abstract][Full Text] [Related]
14. Structural determinants of phosphoinositide 3-kinase inhibition by wortmannin, LY294002, quercetin, myricetin, and staurosporine.
Walker EH; Pacold ME; Perisic O; Stephens L; Hawkins PT; Wymann MP; Williams RL
Mol Cell; 2000 Oct; 6(4):909-19. PubMed ID: 11090628
[TBL] [Abstract][Full Text] [Related]
15. Acute regulation of the epithelial Na+ channel by phosphatidylinositide 3-OH kinase signaling in native collecting duct principal cells.
Staruschenko A; Pochynyuk O; Vandewalle A; Bugaj V; Stockand JD
J Am Soc Nephrol; 2007 Jun; 18(6):1652-61. PubMed ID: 17442787
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, biological evaluation and molecular modelling of sulfonohydrazides as selective PI3K p110alpha inhibitors.
Kendall JD; Rewcastle GW; Frederick R; Mawson C; Denny WA; Marshall ES; Baguley BC; Chaussade C; Jackson SP; Shepherd PR
Bioorg Med Chem; 2007 Dec; 15(24):7677-87. PubMed ID: 17869522
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of neutrophil oxidative burst and granule secretion by wortmannin: potential role of MAP kinase and renaturable kinases.
Sue-A-Quan AK; Fialkow L; Vlahos CJ; Schelm JA; Grinstein S; Butler J; Downey GP
J Cell Physiol; 1997 Jul; 172(1):94-108. PubMed ID: 9207930
[TBL] [Abstract][Full Text] [Related]
18. Structure and ligand-based design of mTOR and PI3-kinase inhibitors leading to the clinical candidates VS-5584 (SB2343) and SB2602.
Poulsen A; Nagaraj H; Lee A; Blanchard S; Soh CK; Chen D; Wang H; Hart S; Goh KC; Dymock B; Williams M
J Chem Inf Model; 2014 Nov; 54(11):3238-50. PubMed ID: 25317974
[TBL] [Abstract][Full Text] [Related]
19. R-Ras3, a brain-specific Ras-related protein, activates Akt and promotes cell survival in PC12 cells.
Kimmelman AC; Osada M; Chan AM
Oncogene; 2000 Apr; 19(16):2014-22. PubMed ID: 10803462
[TBL] [Abstract][Full Text] [Related]
20. Discovery of 4-morpholino-pyrimidin-6-one and 4-morpholino-pyrimidin-2-one-containing Phosphoinositide 3-kinase (PI3K) p110β isoform inhibitors through structure-based fragment optimisation.
Giordanetto F; Wållberg A; Cassel J; Ghosal S; Kossenjans M; Yuan ZQ; Wang X; Liang L
Bioorg Med Chem Lett; 2012 Nov; 22(21):6665-70. PubMed ID: 23010274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
